<?xml version="1.0" encoding="UTF-8"?>
<p>Another evidence of CP efficiency was examined by Qin et al. in 2006. They prepared a safe SARS-CoV vaccine in monkeys; findings revealed that the use of purified inactivated SARS-CoV vaccine could induce high levels of neutralizing antibody and protect the monkeys from the SARS-CoV[
 <xref rid="ref016" ref-type="bibr">16</xref>]. Taken together, these studies show that CP transfusion has a promising potential to be used in COVID-19 treatment.
</p>
